Literature DB >> 20021381

The interface between Alzheimer's disease, normal aging, and related disorders.

R A Armstrong1.   

Abstract

Since the earliest descriptions of Alzheimer's disease (AD), the presence of senile plaques (SP) and neurofibrillary tangles (NFT) have been regarded as the typical pathological hallmarks of the disease. Studies over the last twenty years, however, have reported a considerable degree of heterogeneity within the AD phenotype and as a consequence, an overlap between the pathological features of AD not only with normal aging, but also with disorders related to AD. This review discusses: 1) the degree of heterogeneity within AD, 2) the concept of an 'interface' between disorders, 3) the nature and degree of the interface between AD and normal aging, vascular dementia (VD), the tauopathies, synucleinopathies, and prion disease, and 4) whether the original status of AD should be retained or whether AD, normal aging, and the related disorders should be regarded as representing a 'continuum' of neuropathological change.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20021381     DOI: 10.2174/1874609810801020122

Source DB:  PubMed          Journal:  Curr Aging Sci        ISSN: 1874-6098


  4 in total

1.  Early biomarkers for post-stroke cognitive impairment.

Authors:  Lai Qian; Lidong Ding; Liqun Cheng; Xiaolei Zhu; Hui Zhao; Jiali Jin; Dening Guan; Bing Zhang; Xuemei Chen; Yun Xu
Journal:  J Neurol       Date:  2012-03-10       Impact factor: 4.849

2.  Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes.

Authors:  Diego Iacono; Susan M Resnick; Richard O'Brien; Alan B Zonderman; Yang An; Olga Pletnikova; Gay Rudow; Barbara Crain; Juan C Troncoso
Journal:  J Neuropathol Exp Neurol       Date:  2014-04       Impact factor: 3.685

3.  Size frequency distribution of the beta-amyloid (abeta) deposits in dementia with Lewy bodies with associated Alzheimer's disease pathology.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

Review 4.  Association of Blood Amyloid Beta-Protein 1-42 with Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Hui Chen; Sichun Gu; Xiaoying Liu; Anjie Xie; Changde Wang
Journal:  Biomed Res Int       Date:  2022-03-30       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.